ONO PHARMA LTD (OPHLF)

Overview Data Buy Sell Hold P&P Help

Quote Price $56.40 Price change for today in $ 0.00 Price change for today in % 0.00 Open Price $0.00 Previous Close $56.40 Daily Range $0.00 - $0.00 52-Week Range $48.70 - $58.35 Volume 0     No brokerage coverage for OPHLF   Description Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals.   8-2 Kyutaromachi 1-chome Chuo-ku Osaka, M0 -, JPN Phone: 81 6 6263 5670 Fax: 81 6 6263 2950 Web: http://www.ono.co.jp Industry:MED-DRUGS Sector: Medical Fiscal Year End:March Last Reported Quarter:03/31/12 Next EPS Date:-

Capital Structure Solvency and Cash Flow No comments yet. Be the first

Governance Social Responsibility and Employee Relations No comments yet. Be the first

Acquisitions Divestitures and Joint Ventures No comments yet. Be the first

Recent and Upcoming Events May 04, 2012 03:52 Bharat Book Bureau: Ono Pharmaceutical Co., Ltd. - Strategy and SWOT Report Jan 20, 2012 00:49 Ono Pharmaceutical Company Chooses Medidata Rave for Its Enterprise EDC/CDM Solution Jan 18, 2012 22:23 ONO PHARMACEUTICAL COMPANY SELECTS MEDIDATA RAVE AS ENTERPRISE.. Jan 18, 2012 16:00 Ono Pharmaceutical Company Selects Medidata Rave as Enterprise EDC/CDM Solution Dec 15, 2011 23:50 Receptos and Ono Form Collaboration with Focus on Bioactive Lipid Discovery Research Dec 12, 2011 20:00 Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research Dec 04, 2011 23:45 Asterand's Subsidiary BioSeek Reaches Milestone In Drug Discovery Collaboration with Ono Pharmaceutical Nov 30, 2011 11:30 Asterand's Subsidiary BioSeek Achieves A Research Milestone In Drug Discovery Collaboration With Ono Oct 14, 2011 15:17 Progenics Pharmaceuticals to Present at NewsMakers Conference Oct 11, 2011 08:00 Progenra, Inc. and Ono Pharmaceutical Co., Ltd. Enter into Research Collaboration Oct 07, 2011 01:17 Merck Serono and Ono Pharmaceutical Partner to Develop Oral Multiple Sclerosis Drug and Cancer Immunotherapy Sep 21, 2011 14:40 Bristol-Myers Squibb signs agreement with Ono Pharmaceutical for ORENCIA Sep 21, 2011 04:43 Ono and Astellas launch osteoporosis drug in Japan Sep 21, 2011 04:43 Ono receives approval for additional indication of type-2 diabetes drug Sep 20, 2011 07:17 KAI signs R&D partnership with Ono Pharmaceutical

Major Risks No comments yet. Be the first

---

Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 08:36:54 CDT by WikiMigrationBot.